Veracyte, Inc.
VCYT
Rang in aandelen
#4358
Veracyte, Inc. operates as a diagnostics company in the United States and... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Aandeelprijs
$44.93
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$3.61B
Verandering (1 dag)
2.57%
Verandering (1 jaar)
24.45%
Land
US
Handel Veracyte, Inc. (VCYT)
Categorie
Healthcare
Winst voor Veracyte, Inc. (VCYT)
Winst in Jun 2026 TTM: $108.94M
Volgens de meest recente financiële verslagen van Veracyte, Inc. bedraagt de huidige winst van het bedrijf $108.94M. In 2023 behaalde het bedrijf een winst van $-76.61M, een daling ten opzichte van de winst van 2022, die $-36.43M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Veracyte, Inc. van 2011 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $108.94M | 323.17% |
| 2024 | $25.74M | -133.60% |
| 2023 | $-76.61M | 110.32% |
| 2022 | $-36.43M | -55.39% |
| 2021 | $-81.65M | 133.89% |
| 2020 | $-34.91M | 177.08% |
| 2019 | $-12.60M | -45.22% |
| 2018 | $-23.00M | -25.82% |
| 2017 | $-31.00M | -1.13% |
| 2016 | $-31.36M | -6.96% |
| 2015 | $-33.70M | 14.74% |
| 2014 | $-29.37M | 14.83% |
| 2013 | $-25.58M | 37.17% |
| 2012 | $-18.65M | 29.10% |
| 2011 | $-14.45M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.61B | 6,884.58% |
US
|
|
| $4.76B | 4,271.21% |
US
|
|
| $-252.70M | -331.96% |
US
|
|
| - | - |
CN
|
|
| $1.66B | 1,421.94% |
US
|
